The number of people making the switch from tobacco to electronic cigarettes is growing at a very fast rate each month because nowadays everyone understands the health risks and the implications smoking has on our lives and societies. Quitting tobacco has been a preoccupation for many smokers along the decades and big pharmaceutical companies took advantage of this situation by coming up with different types of alternative nicotine delivery systems like inhalers, patches and gum which have helped numerous people to give up on the nasty habit.
A decade ago if one wanted to cut down or quit tobacco entirely he was presented with two alternatives: go cold turkey or ask the physician for a prescription for some nicotine patches and gum. And since not everyone was able to go ‘cold turkey’ and give up smoking in a single day, many preferred using the nicotine patches, inhalers and the gum. While these methods delivered far better results than fighting addiction solely, people often relapsed or were unable to follow the cure properly simply because they felt isolated in their battle and lacked the motivation.
Nowadays, electronic cigarettes offer a far more popular alternative, and one reason behind this popularity is the fact that these devices have given birth to a whole community. Using ecigs is an applaudable practice and surely connecting with people all across the globe that managed to quit tobacco entirely is motivating enough. Also there is a wide range of flavors and different nicotine concentrations but the most important aspect of ecigs is that they mimic the whole smoking experience to the last detail.
It’s comes as no surprise that so many former smokers are now enjoying a much healthier lifestyle because of these devices but at the same time the big pharmaceutical companies have started to notice the competition. Instead of buying traditional smoking cessation products people are now buying electronic cigarette in stores and online and these devices aren’t even allowed to be advertised as nicotine alternative products.
This is why one of the biggest players of the pharmaceutical industry – GSK – told Reuters that at a given point in time they decided to fight the competition directly by releasing their own brand of electronic cigarettes. However, the idea disappeared swiftly and the company decided that it was better to create consumer health joint venture with another big pharma player and become no. 1 in the nicotine alternatives segment.
E-cigarettes are battery operated gizmos that heat up a flavored e-liquid and turn it in an inhalable nicotine infused mist giving the same sensation as puffing on a tobacco cigarette, but without any of the smoke or carcinogens.
Some of the concerns of ecigs is that they can act as a gateway and get minors hooked up on nicotine, but recent studies showed this is not the case and also that sweet flavors mostly appeal to adults.